Home » Debiopharm, Pharmaleads Sign License Agreement for Pain Treatment
Debiopharm, Pharmaleads Sign License Agreement for Pain Treatment
Debiopharm Group, a global biopharmaceutical development specialist … and Pharmaleads SAS, a science driven drug discovery and early development company, announced the signature of an exclusive license agreement for the development, registration and commercialisation of a small molecule called Debio 0827 or PL37, about to enter phase I clinical trials.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May